Showing results (1791-1800 of 8,963) with videos related to
Sort By:
Pageof 897
Journal of Hepatology|November 9, 2017
The chaperone dynein LL1 mediates cytoplasmic transport of empty and mature hepatitis B virus capsidsQuentin Osseman, Lara Gallucci, Shelly Au, et al.Journal of Hepatology|September 20, 2017
Targets for immunotherapy of liver cancerTim F Greten, Bruno SangroJournal of Hepatology|September 10, 2017
Dusp14 protects against hepatic ischaemia-reperfusion injury via Tak1 suppressionXiaozhan Wang, Wenzhe Mao, Chun Fang, et al.Journal of Hepatology|September 23, 2017
Effectiveness of ravidasvir plus sofosbuvir in interferon-naïve and treated patients with chronic hepatitis C genotype-4Gamal Esmat, Tamer Elbaz, Maissa El Raziky, et al.Journal of Hepatology|October 3, 2017
Controversies in clinical trials for alcoholic hepatitisSarah R Lieber, John P Rice, Michael R Lucey, et al.Journal of Hepatology|August 28, 2017
Disease outcomes in a cohort of women in Ireland infected by hepatitis C-contaminated anti-D immunoglobulin during 1970sPatricia Garvey, Niamh Murphy, Paula Flanagan, et al.Journal of Hepatology|September 2, 2017
Hepatitis E virus-induced primary cutaneous CD30(+) T cell lymphoproliferative disorderVincent Mallet, Julie Bruneau, Julien Zuber, et al.Journal of Hepatology|March 5, 2016
Counter-regulation of rejection activity against human liver grafts by donor PD-L1 and recipient PD-1 interactionXiao-Lei Shi, Shanta Mancham, Bettina E Hansen, et al.Journal of Hepatology|March 8, 2016
Constitutive androstane receptor (Car)-driven regeneration protects liver from failure following tissue lossChristoph Tschuor, Ekaterina Kachaylo, Përparim Limani, et al.Journal of Hepatology|December 15, 2015
Lactic acidosis in patients with hepatitis C virus cirrhosis and combined ribavirin/sofosbuvir treatmentMartin-Walter Welker, Stefan Luhne, Christian M Lange, et al.Pageof 897